Evidence map›Paper›PMID 41060164›Full record

ArticleBiomedica : revista del Instituto Nacional de Salud2025

Identification of a variant in the USH1G gene in a family with Usher syndrome

Nancy Gélvez, Greizy López, Marta L Tamayo

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Biomedica : revista del Instituto Nacional de Salud, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nancy GélvezInstituto de Genética Humana, Pontificia Universidad Javeriana, Bogotá, D. C., Colombia.ORCID 0000-0002-3925-1451
Greizy LópezInstituto de Genética Humana, Pontificia Universidad Javeriana, Bogotá, D. C., Colombia.ORCID 0000-0001-9380-0792
Marta L TamayoInstituto de Genética Humana, Pontificia Universidad Javeriana, Bogotá, D. C., Colombia.ORCID 0000-0001-8297-3970

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Usher syndrome is characterized by congenital sensorineural hearing loss, retinitis pigmentosa, and vestibular dysfunction. It is the most common cause of deafblindness worldwide. It is classified into three clinical types and twelve genetic subtypes. We report a case of a family affected by Usher syndrome due to a variant in the USH1G gene, coding for the SANS protein. The ocular and auditory tests were performed for clinical confirmation of the diagnosis. The molecular study consisted of a next-generation sequencing panel containing 14 genes associated with Usher syndrome: MYO7A, USHC1, CDH23, PCDH15, USHG1, CIB2, USH2A, ADGRV1, WHRN, CLRN1, HARS, PDZD7, CEP250, C2orf71. We present the case of a 13-year-old girl from a consanguineous Colombian family diagnosed with Usher syndrome type 1G. Clinical evaluations confirmed auditory, vestibular, and ocular alterations. Molecular analysis identified the homozygous p.Glu171Ter variant in the USH1G gene. We highlight the importance of an early diagnosis of Usher syndrome. Although the variant frequency in the USH1G gene is low, it should not be underestimated; the exact etiology must be identified in these families. We recommend establishing a panel with Colombianspecific variants to perform more accurate Usher syndrome diagnoses, and in the future, to guide the development of gene therapies.

Indexed as

Usher SyndromesAdolescentConsanguinityFemaleHomozygoteHumansMaleNerve Tissue ProteinsPedigreeNerve Tissue ProteinsUSH1G protein, humanColombiaDNA mutational analysisgeneticshearing loss, sensorineuralretinitis pigmentosaUsher syndromes

Identifiers

PMID41060164
PMCPMC12542892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.